Clinical Trials
9 trialsNCT00942968 2024-04-18
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Pfizer
Phase 4 Completed
NCT03297359 2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2 Terminated
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed
NCT02073682 2019-03-06
Cancer Venous Thromboembolism (VTE)
Daiichi Sankyo
Phase 3 Completed
NCT00041782 2018-10-31
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT02746185 2018-08-13
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated